Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Saved in:
| Title: | Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. |
|---|---|
| Authors: | Okada T; Division of Nephrology and Blood Purification Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-0012, Japan. tad-okada@umin.ac.jp., Sakaguchi T; Division of Nephrology and Blood Purification Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-0012, Japan., Hatamura I; First Department of Pathology, Wakayama Medical University, Wakayama, Japan., Saji F; Division of Nephrology and Blood Purification Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-0012, Japan., Negi S; Division of Nephrology and Blood Purification Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-0012, Japan., Otani H; Division of Nephrology and Blood Purification Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-0012, Japan.; Ryoshukai Wakayama Kidney Disease Clinic, Wakayama, Japan., Muragaki Y; First Department of Pathology, Wakayama Medical University, Wakayama, Japan., Kawachi H; Department of Cell Biology, Institute of Nephrology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Shigematsu T; Division of Nephrology and Blood Purification Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-0012, Japan. |
| Source: | Clinical and experimental nephrology [Clin Exp Nephrol] 2009 Oct; Vol. 13 (5), pp. 438-446. Date of Electronic Publication: 2009 May 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7799 (Electronic) Linking ISSN: 13421751 NLM ISO Abbreviation: Clin Exp Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
